Recent health news highlights include high costs of weight-loss drugs like Wegovy, Septerna's strong Nasdaq debut, ...

IterumTherapeutics今日宣布，美国FDA已批准其药品Orlynvah（sulopenem etzadroxil & ...

Highlights,Newell Brands reports a decrease in third-quarter net sales for 2024.,The company focuses on a strategic business ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...

Highlights,Iterum Therapeutics receives FDA approval for its new drug, ORLYNVAH.,ORLYNVAH targets uncomplicated urinary tract ...

北京时间2024年10月26日02时33分，Allovir, Inc.（ALVR.us）股票出现波动，股价快速 拉升 5.06%。截至发稿，该股报0.830美元/股，成交量8.9091万股， 换手率 0.08%，振幅8.10%。

Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...

The FDA has cleared Iterum’s oral antibiotic for certain patients with uncomplicated urinary tract infections (uUTIs) who ...

This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...

"ITERUM" (until June 6, 2024 - "PET Baltija") is one of the largest polyethylene terephthalate (PET) processing companies in Northern Europe and the largest PET processing company in the Baltic region ...

The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...